TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Elicio Therapeutics Inc. (ELTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 26 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
11 11 27 12 47 97 23 27 28 26
2.1 2.6 26 6.1 40 91 11 16 21 19
1.4 2.1 26 5.6 35 89 7.8 13 18 19
1.4 2.1 26 5.6 35 89 7.8 13 18 19
0.6 0.5 0.1 0.4 5.0 0.8
0.0 -0.1 -4.6 0.2 4.2
1.4 1.0 0.9 8.5
6.8 6.6 7.7 30 138 15 14 16 39 24
1.1 1.1 7.4 27 107 11 6.9 9.8 12 8.1
0.1 0.1 6.9 81 1.0 0.7 0.9 0.9 1.0
0.2 0.0 0.5 11 5.6 4.7 2.8 4.4 1.0 0.7
20 9.4
1.7 2.3 19 -19 -90 82 8.9 11 -11 1.6
1.7 2.3 -40 -80 -161 -215 -107 -142 -194 -234
0.0 0.0 2.9 8.2 8.2 3.2 3.1 5.1 12 15

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?